logo
logo
Sign in

Research Progress about Biomarkers for Kidney Disease

avatar
ivan chen

Kidney disease is becoming "younger" and "popular". Treatment methods for kidney disease include drug treatment, alternative treatment, biological treatment, etc.

Among them, biotherapy has become a hot spot in clinical research. Polyclonal anti-lymphocyte antibodies, fusion proteins, cytokines, stem cells and other related biological agents have been gradually applied to various primary and secondary nephropathy, its efficacy and safety was further affirmed.

At the same time, more new biological agents are still in the experimental and clinical trials.

Recently, the International Journal of Clinical Medical Research "American Society of Nephrology Clinical Journal" and "Arthritis Care and Research" have published a series of research results. Let’s take a look!

For the first time in the population cohort, the association between specific amino acids and acylcarnitine profiles and the risk of decreased renal function and the risk of hyperuricemia after 6 years and dietary factors were revealed.

The study shows that renal failure or gout caused by chronic kidney disease and hyperuricemia seriously affects health. Given the hidden nature of chronic kidney disease and hyperuricemia, early biomarkers were discovered to carry out early prediction and intervention, which is critical to the prevention and control of such diseases.

This research provides an important evidence-based basis for the early diagnosis and intervention of such diseases. However, at present, there is still a lack of research on prospective cohorts to explore dietary and metabolomics markers and disease risk.

The severe challenges faced by the prevention and treatment of chronic kidney disease are mainly manifested in the prevention and treatment of chronic kidney disease with the "three high" of high prevalence, high rate of combined cardiovascular disease and high mortality, as well as low awareness, low prevention rate and awareness of combined cardiovascular disease. Routine urine and regular kidney function tests can help detect signs of kidney disease early.

In order to accelerate the research of kidney disease and overcome kidney disease as soon as possible, Creative Biolabs has developed and launched research and testing products related to kidney function tests.

Creative Biolabs works as an outstanding expert in the antibody development field. We have established a proprietary and robust in vitro diagnostic (IVD) platform that enables us to provide first-class IVD antibody development services to our global clients, thereby facilitating and speeding their path to the development of antibody-based diagnostic immunoassays.

collect
0
avatar
ivan chen
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more